baber/WOPTO huggingface dataset:
Patent GB-1303826-A (GB)
IPC: G09F1/10
Filed: 1970-04-17
Abstract: 1303826 Showcard mounts and stands TRENDMARK Ltd 19 April 1971 [17 April 1970] 18530/70 Headings A4H and A4X [Also in Division G5] A display device comprises a showcard 6 mounted between two arms 3 of a bracket 1, the arms converging towards their free ends and each arm being provided with two channel forming members 4 between which the showcard is located. Complementary fasteners may be provided on the members and the showcard. Opposed edges of the showcard have diverging portions which are complementary with the converging arms. The bracket may be used as a stand.
Patent GB-1304848-A (GB)
IPC: A63B21/06
Filed: 1969-07-02
Abstract: 1304848 Exercising apparatus M CLEMENT 1 Oct 1970 [2 July 1969] 33323/69 Heading A6M An exerciser comprises a base on which a seat and an overhead structure, which carries pulleys, are mounted. As shown the exerciser comprises a frame with a base portion 1, a seat frame 2 on which is a seat 4, and a top 3, there being projecting beams 7 and 8 secured to the base and the top having hooks such as 71, 73 and 74 and 81, 83 and 85 respectively to which sheaves 72, 82 and 84, respectively can be attached so that a cord 9 carrying a weight 10 may run over them. Further hooks 75 and 76 on uprights 5 and 6 are also provided. The patient, sitting on the seat 4 has his leg held by a holder 20-22 and may have his foot in a movable harness consisting of a platform 24 and straps 23 to eyes on which harness the end of a cord 9 may be attached. Various exercises for the legs are described using different arrangements of sheaves, cords and weights. The apparatus may also be used with the patient standing and a body harness having hooks is described for one particular exercise in this position. Instead of a single seat 4, four seats may be mounted in a cruciform arrangement.
Patent GB-1305465-A (GB)
IPC: H01M10/52
Filed: 1970-10-13
Abstract: 1305465 Battery charging systems OLDHAM INTERNATIONAL Ltd 13 Oct 1970 48648/70 Heading H2H [Also in Division H1] A battery charging apparatus for use with miners' cap lamps comprises a change-over switch 208, 210 by means of which a battery 202 may be connected to charger 204 or to a lamp 206 to permit simulation of the charge-discharge cycle of normal use. The battery 202 is sealed (see Division H1) and a transducer 218 measures the pressure on the battery case and provides signals for actuating a recording system 220.
Patent GB-1308690-A (GB)
Title: High protein fruit-type beverage and processing therefor
IPC: A23J3/34
Filed: 1970-09-22
Abstract: 1308690 Proteinaceous beverages DAYLIN LABORATORIES Inc 22 Sept 1970 45033/70 Heading C6E [Also in Division C3] A process of preparing a high protein, mildly acidic beverage comprises effecting controlled proteolytic hydrolysis of a beverage base (can be water) containing added foreign protein with dispersed proteolytic enzymes (specified), inactivating the proteolytic enzyme (by pasteurization) when the resultant hydrolyzed protein is free of objectionable or meaty taste and odour and is substantially soluble in an acidity which is suitable for a beverage, and adjusting the liquid content of the beverage base to that of a mildly acidic beverage in which the hydrolyzed protein is lastingly dispersed in a storage-stable liquid wherein the hydrolysate does not contribute a turbidity or precipitate to the beverage. Protein materials: gelatine, casein, egg albumen and/or soya. The hydrolysis, which involves heating at a temperature of 33-70‹ C. for a maximum period of an hour, may be carried out by adding both protein and proteolytic enzymes directly to fruit or berry juice. The product of the hydrolysis may then be concentrated and frozen for storage and diluted later. Alternatively, the reaction may take place in aqueous medium and the juice added for adjusting the liquid content. The beverage product typically contains between 1 and 8% by weight of hydrolyzed protein and exhibits a pH of 2À5-5À0. Formulations of fruit and non-fruit blends carbonated and non- carbonated, are disclosed.
Patent GB-1313135-A (GB)
Title: Vapour trap for a vapour vacuum pump
IPC: F04F9/06
Filed: 1969-04-28
Abstract: 1313135 Vapour vacuum pump vapour traps EDWARDS HIGH VACUUM INTERNATIONAL Ltd and CAMBRIDGE SCIENTIFIC INSTRUMENTS Ltd 28 April 1970 [28 April 1969] 21602/69 Heading F1E A vapour trap for a vapour vacuum pump comprises a refrigerant reservoir 2 having a passage 4 containing trapping surfaces 6, and surrounded by a fluid cooled housing 14 which supports additional trapping surfaces 24 formed by louvres, so that in the absence of refrigerant e. g. liquid nitrogen, the surfaces 6 are screened by the louvres 24 and the housing 14 from external heat sources. The surfaces 6 may be parallel seats and the louvres 24 may be frusto-conically shaped. The resevoir 2 may be supported by ties or struts joined to the housing 14 and may have a re-entrant skirt (30) Fig.2 (not shown), or an external cylindrical extension (28), Fig. 3 (not shown), to reduce the solid angle through which heat reaches the surface 6. The latter are mounted on supports 8.
Patent GB-1339190-A (GB)
Title: Convertible furniture arrangements
IPC: A47C17/04
Filed: 1971-10-29
Abstract: 1339190 Chairs convertible to beds; upholstery DURA-FOLD MACHINE WORKS. Inc 29 Oct 1971 50391/71 Headings A4J and A4M A chair which is convertible into a chaise longue or a bed has a backrest frame 12 pivotally mounted on a seat frame 14 about an axis 58 and a foot-rest frame 16 horizontally slidable in a slideway defined by channel members 34 which form part of the seat frame, the backrest being locked in one of a number of positions by the engagement of spring biased retractable locking rods 62 in one of a number of holes 82 in members 24 of the seat frame. The foot rest frame has wedge-shaped side members 90 which define an upwardly and forwardly cushion supporting surface seat, back and foot rest cushions 20, 18 and 22 respectively, each comprise polyurethane foam in an impervious vinyl covering with an opening for restricted flow of air into and out of the cushion when weight is taken off the cushion or applied thereto, the opening comprising a reentrant fold 108 and overlapped flaps 104, 106. The foam of the seat and backrest cushions is supported by plywood or the like.
Patent GB-1342711-A (GB)
Title: Liquid fuel injection pumping apparatus
Inventor: MIRACKI Z
IPC: F02M41/14
Filed: 1970-05-30
Abstract: 1342711 Fuel injection pumps C A V Ltd 26 May 1971 [30 May 1970] 26171/70 Heading F1A A fuel injection pump is provided with temperature sensitive means operable to cause retardation in the timing of injection and excess fuel supply when starting an associated engine from cold. The pump is of the kind, Fig.1, comprising a rotary distributor 11 having radial cylinders 12 in which pumping plungers 13 are reciprocated by indirect co-operation with a rotatably adjustable cam ring 17. To control the quantity of fuel admitted to the cylinders 12, a metering chamber 22 containing a freely slidable piston 21 is provided. The chamber 22 receives fuel through a port 23 during the plunger's injection strokes and is subsequently expelled through the port 23 and a passage 20a into the cylinders 12 during the suction stroke. Excursion of the free piston 21 and the angular position of the cam ring 17 are determined by the axial positions of spring loaded pistons 27, 18, respectively. Both pistons 27, 18 move in response to a speed dependent fluid pressure supply (not shown). During cold start-up a wax type temperature sensitive element 40 moves a cam member 38 to a position in which pins 33, 34 allow pistons 27, 18 to assume their excess fuel and retarded injection positions, respectively. In an alternative arrangement, Fig.4 (not shown) a temperature element (55) causes a throttle valve (50) to delay the application of the speed dependent supply to the pistons 18, 27.
Patent GB-1343327-A (GB)
Title: Heat-activated transfers
IPC: B44C1/17
Filed: 1972-05-12
Abstract: 1343327 Heat transfers LETRASET INTERNATIONAL Ltd 12 May 1972 [12 May 1971] 14483/71 Heading B6C In order to remove the need for after-heat treatment when applied to polyethylene or polypropylene surfaces the heat transfer of Specification 1,290,403 is printed with an ink comprising a thermoplastic linear polyamide resin.
Patent GB-1347245-A (GB)
Title: Analytical apparatus and method of analysis
IPC: G01N21/67
Filed: 1970-04-28
Abstract: 1347245 Gas chromatography IMPERIAL CHEMICAL INDUSTRIES Ltd 19 April 1971 [28 April 1970 27 Aug 1970 2 Sept 1970] 20366/70 41246/70 and 41950/70 Heading B1X [Also in Divisions G1 and G2] In an apparatus for the analysis of a mixture of organic compounds the compounds are separated using a gas chromatographic column, the gaseous effluents from the column are passed together with a plasma forming gas, e.g. Helium, Argon or Neon, and oxygen, nitrogen or hydrogen which are used as scavengers for carbon to a quartz tube in which a plasma is induced by a Tesla coil and radiation from the plasma is directed to a prism or diffraction grating spectrometer, the readings of the spectrometer being used to determine the elements in the compounds and the emiprical formula of the compounds in the mixture. A flame ionisation detector may be connected to the outlet of the chromatographic column such that part of the gaseous effluent passes to the quartz tube and part to the flame ionisation detecter which is also used to determine the elements in the compounds, the results obtained being compared with those obtained by the spectrometer. The spectrometer may include a number of photo-multipliers which are positioned to detect radiation of different frequencies, one photo-multiplier being used to detect second-order carbon radiation.
Patent IL-100010-A (IL)
Title: Avirulent strains of salmonella comprising a mutation in a cdt gene and immunogenic compositions containing said avirulent salmonella strains
IPC: C12N15/01
Filed: 1991-11-08
Abstract: This invention provides immunogenic compositions for the immunization of a vertebrate or invertebrate comprising an avirulent derivative of S. typhi. The derivatives having a mutation of the cya and/or crp and/or cdt genes. The invention also provides immunogenic compositions for the immunization of a vertebrate and invertebrate comprising an avirulent derivative of the above type which is capable of expressing a recombinant gene derived from a pathogen of said vertebrate or invertebrate individual to produce an antigen capable of inducing an immune response against said pathogen. Other embodiments of the invention include methods of preparing immunogenic compositions from these strains, and strains useful in the preparation of the immunogenic compositions, as well as methods of stimulating the immune system to respond to an immunogenic antigen of S. typhi by administration of the immunogenic composition.
Patent IL-107987-A (IL)
Title: Dolastatin analogs their preparation and pharmaceutical compositions containing them
IPC: A61K38/08
Filed: 1993-12-10
Abstract: Novel peptides of formula (I) in which R<1>, R<2>, X, A, R<3>, B, D, E, R<7>, M, Q, a, b and d have the meanings stated in the description, and the preparation thereof are described. The novel substances have an antineoplastic effect.
[WO9413695A1]
Patent IL-117972-A (IL)
Title: Compact microwave lamp
IPC: F21S2/00
Filed: 1996-04-18
Abstract: A microwave lamp having a compact structure utilizing a coupling slot which is located off center in one direction and a canted bulb stem which is located off center in the opposite direction. A non-conventional waveguide is used which has about the width of a WR-284 waveguide and about the length of a WR-340 waveguide.
Patent IL-125508-A (IL)
Title: Process for preserving product quality of lychee
Inventor: MORN ISRAEL
IPC: A23B7/157
Filed: 1998-07-26
Abstract: An improved process for preserving the product quality of lychee fruit, particularly the pericarp color comprising the following steps; (i) treating fresh lychee fruit with cold water; (ii) treating the lychee fruit with hot water; (iii) treating the lychee fruit with hydrochloric acid; (iv) drying the liquid on the fruit.
[US6093433A]
Patent IL-128727-A (IL)
Title: POLYNUCLEOTIDE COMPRISING EXONS 1-5,6a AND 8 OF THE VEGF GENE
IPC: C07K14/52
Filed: 1997-09-04
Abstract: The present invention relates to novel VEGF protein products, and nucleic acids encoding these novel protein products, comprising exons 1-6 and 8 of the VEGF gene, and derivatives thereof, and these uses in treating the cardiovascular system and its diseases through effects on anatomy, conduit function, and permeability. VEGF145 and its derivatives have been found to be active mitogens for vascular endothelial cells and to function as angiogenic factors in-vivo. VEGF145 and its derivatives have novel properties compared with previously characterized VEGF species with respect to cellular distribution, susceptibility to oxidative damage, and extra-cellular matrix (ECM) binding ability. The present invention also relates to derivatives of VEGF145 which have altered properties in that they have altered biological activity and altered heparin-binding activity when compared to VEGF145. The present invention provides methods of treating the cardiovascular system, enhancing endothelialization of diseased vessels, and enhancing drug permeation by providing the novel VEGF protein products. The invention also provides expression vectors, compositions, and kits for use in the methods of the invention.
Patent IL-129864-A (IL)
Title: Network security for tcp protocol
Inventor: DANIELY GAD
IPC: H04L/
Filed: 1999-05-10
Abstract: A method for selecting a sequence number for a TCP datagram in a TCP session between a first computer and a second computer, the sequence number being determined from a time-dependent function, the method comprising the steps of: (a) receiving a first TCP datagram by the first computer from the second computer; (b) holding said first TCP datagram for a variable period of time; (c) calculating the sequence number according to the time-dependent function and at least partially according to said variable period of time; (d) preparing a second TCP datagram, said second TCP datagram at least including the sequence number; and (e) sending said second TCP datagram by the first computer to the second computer. The method provides security against TCP spoofing.
Patent IL-138075-A (IL)
Title: Plasmids comprising nucleic sequences encoding immunogen and immunomodulating protein, pharmaceutical compositions comprising the same and use of such plasmids in the manufacture of medicaments
IPC: A61K39/245
Filed: 2000-08-24
Abstract: Improved vaccines which include a nucleotide sequence that encodes immunomodulating protein operably linked to regulatory elements are disclosed. The improved vaccines include DNA vaccines, recombinant vaccines for delivering foreign antigen and live attenuated vaccines. Methods of immunizing individuals are disclosed. Compositions for and methods of treating individuals with autoimmune diseases are disclosed.
Patent IL-148002-A (IL)
Title: Scaling independent copy protection technique for watermarking images
IPC: H04N7/26
Filed: 2002-02-04
Abstract: A robust technique to prevent illicit copying of video information notwithstanding the use of image scaling. A watermark is embedded into the video signal (e.g., DVD's content or other video sources) at different scales (i.e., sizes). The watermark is maintained at each scale for a predetermined time duration that is sufficient to allow the detector circuit in a DVD-recorder, DVHS recorder, DVCR, or any other digital format recorder to detect, extract, and process information contained in the watermark. At the end of the predetermined time duration, the watermark is changed to a different scale preferably on a pseudo-random basis to ensure that each one of all the scales in a predetermined scaling range is achieved a predetermined number of times. Thereby the recorder shuts off a number of times during play of the content, each time the detector circuit senses the watermark.
Patent IL-161283-A (IL)
Title: Rear-projection screen and process for its production
IPC: G03B21/62
Filed: 2004-04-04
Abstract: A back projection screen including at least one light scattering polymethyl methacrylate (PMM) layer of thickness 0.05-4 mm having spherical particles of particles size 5-35 micron in a concentration of 2-60 wt.% on the total weight of the PMM layer, the particles having a refractive index difference compared with the PMM matrix of 0.02-0.2 is new.  A back projection screen including at least one light scattering polymethyl methacrylate (PMM) layer of thickness 0.05-4 mm having spherical particles of particles size 5-35 micron in a concentration of 2-60 wt.% on the total weight of the PMM layer, the particles having a refractive index difference compared with the PMM matrix of 0.02-0.2, where the concentration of spherical particles cp, the thickness of the light scattering PMM layer ds, and the particle size of the spherical plastics particles Dp are selected so that the cp.ds/Dp3 ratio is 0.0015-0.015 wt.%.mm/micron3 and the ratio of the mean surface roughness of the polymethyl methacrylate layer Ra to the particle size of the spherical plastics layer dscp/ds = 0.05-0.4. An Independent claim is included for a process for preparing the screen by extrusion of a molding composition.
Patent IL-165086-A (IL)
Title: Pyridyl cyanoguanidines, pharmaceutical compositions comprising them and uses thereof for the preparation of medicaments
IPC: A61K31/4425
Filed: 2004-11-08
Abstract: Pyridyl cyanoguanidine compounds of the general formula I wherein A, X<SUB>1</SUB>, X<SUB>2</SUB>, X<SUB>3</SUB>, Y<SUB>1</SUB>, Y<SUB>2</SUB>, Y<SUB>3</SUB>, R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>5</SUB>, R<SUB>6 </SUB>and n are as indicated in the description are suitable as prodrugs in human and veterinary therapy of proliferative diseases such as cancers.
Patent IL-166783-A (IL)
Title: 6-[(pyridin-2-yl-methyl)-amino]-9h-purine-2-yl-amino alcohols, process for their preparation and pharmaceutical compositions comprising them
IPC: A61P31/12
Filed: 2005-02-09
Abstract: The present invention relates to compounds of formula 1 or pharmaceutically acceptable salts thereof, wherein one of R1 and R2 is methyl, ethyl or isopropyl, and the other is H; R3 and R4 are each independently H, branched or unbranched C1-C6 alkyl, or aryl, and wherein at least one of R3 and R4 is other than H; R5 is a branched or unbranched C1-C5 alkyl group or a C1-C6 cycloalkyl group, each of which may be optionally substituted with one or more OH groups; R6, R7, R8 and R9 are each independently H, halogen, NO2, OH, OMe, CN, NH2, COOH, CONH2, or SO2NH2. A further aspect of the invention relates to pharmaceutical compositions comprising compounds of formula 1, and the use of said compounds in treating proliferative disorders, viral disorders, CNS disorders, diabetes, stroke, alopecia or neurodegenerative disorders.
Patent IL-173434-A (IL)
Title: Systems, methods and devices for defending a network
IPC: H04L69/40
Filed: 2006-01-30
Abstract: Certain exemplary embodiments comprise a method comprising: within a backbone network (1300): for backbone network traffic addressed to a particular target (1710) and comprising attack traffic and non-attack traffic, the attack traffic simultaneously carried by the backbone network (1300) with the non-attack traffic: redirecting at least a portion of the attack traffic to a scrubbing complex (1400,1500); and allowing at least a portion of the non-attack traffic to continue to the particular (1710) target without redirection to the scrubbing complex.
Patent IL-176702-A (IL)
Title: Derivatives of 1,4-diazabicyclo[3.2.1] octanecarboxamide, preparation method thereof and use of same in therapeutics
IPC: C07D519/00
Filed: 2006-07-04
Abstract: 4-heterocyclylcarbonyl-1,4-diazacyclo-octane derivatives (I), as individual or mixed enantiomers, bases, solvates and acid addition salts are new. 4-heterocyclylcarbonyl-1,4-diazacyclo-octane derivatives of formula (I), as individual or mixed enantiomers, bases, solvates and acid addition salts are new. X : N or CR 2; P, Q, R and W : N or CR 3; R 1 and R 21-6C alkyl; R 3hydrogen, halo, 1-6C alkyl or alkoxy, nitro, amino, trifluoromethyl, cyano, NR 4R 5, NR 4COR 5, NR 4CONR 5R 6, NR 4COOR 5, NR 4SO 2NR 5R 6, OR 5, OCOR 5, OCOOR 5, OCO-ONR 4R 5. OCOSR 5, COOR 5, COR 5, CONR 4R 5, SR 5, SOR 5, SO 2R 5, SO 2NR 4R 6, or phenyl (optionally substituted by any of the groups indicated for R 3), or R 3 is any of a wide range of heterocyclic groups (het1); R 4, R 5 and R 6halo, 1-6C alkyl, 2-6C alkenyl or alkynyl, 3-8C cycloalkyl, 3-8C cycloalkyl(1-3C)alkyl, 4-8C cycloalkenyl or phenyl, and RNR 4R 5 or NR 5R 6 may complete a heterocycle (het2). The full definitions are given in the DEFINITIONS (Full Definitions) Field. [Image] ACTIVITY : Nootropic; Neuroprotective; Neuroleptic; Antiparkinsonian; Anticonvulsant; Tranquilizer; Antidepressant; Cardiant; Antiulcer; Antismoking. MECHANISM OF ACTION : (I) are ligands for nicotinic receptors, with high selectivity for receptors that include the alpha 7 subunit. The compound 3-(1,4-diazabicyclo[3,2,1]oct-4-yl-carbonyl)-6-methyl-1H-pyrazolo[3,4-b]pyridine hydrobromide had IC 50 for inhibition of binding of tritium-labeled alpha -bungarotoxin to nicotinic receptors that contained the alpha 7 subunit of 0.056 mu M.
Patent IL-181312-A (IL)
Title: Method of inducing folding of a denatured polypeptide and a composition comprising a refolding buffer effective to induce folding of neublastin polypeptide
IPC: A61K/
Filed: 2007-02-13
Abstract: Compositions and methods for folding proteins belonging to the transforming growth factor beta superfamily are disclosed. The compositions and methods allow for the folding of such proteins when produced in an expression system that does not yield a properly folded, biologically active product.
Patent IL-184778-A (IL)
Title: System and methods of acquisition, analysis and authentication of the handwritten signature
IPC: G06V40/30
Filed: 2007-07-23
Abstract: A person making a handwritten signature performs a series of three-dimensional movements with a plane graphical finality. The movements generate kinetic information perceived by a special pen that the signature is performed with (the writing and digital acquisition device for the primary bio-kinetic information). The information, concordant to the afferent bio-kinetic pattern, is collected by included MEMS type acceleration sensors in the pen. The system analyzes the generated information (the signals) and determines the dynamic-biometrical characteristics based upon the biometrical dimension of the information. The characteristics are transformed into data vectors and invariants that are stored in a database. Based on algorithms, the system performs the required comparisons between the spatial kinetics of the specimens and the kinetics of the entrances and obtains distance-type answers. In statistical terms, the results are related to the entire subject database, by interpreting and sampling methods.
Patent IL-191703-A (IL)
Title: Immunogenic composition comprising an antigen, a saponin adjuvant and a lipopolysaccharide
IPC: A61K/
Filed: 2008-05-26
Abstract: The present invention provides a human dose of an immunogenic composition comprising an antigen or antigenic preparation, in combination with an adjuvant which adjuvant comprises an immunologically active saponin fraction derived from the bark of Quillaja Saponaria Molina presented in the form of a liposome and a lipopolysaccharide wherein said saponin fraction and said lipopolysaccharide are both present in said human dose at a level of below 30µg. The present invention further provides an adjuvant composition in a human dose suitable volume comprising between 1 and 30 µg of a lipopolysaccharide and between 1 and 30 µg of an immunologically active saponin fraction presented in the form of a liposome.